TwinPig BioLab Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
8
TwinPig BioLab General Information
Description
Operator of a technology-focused bio-venture intended to develop cancer-preventing drugs. The company leverages research collaborations and a focus on anticancer drugs to expedite the development of life-saving treatments, enabling healthcare professionals to improve the lives of patients.
Contact Information
Website
twinpigbio.comCorporate Office
- Room 501, Seoul Biohub Global Center
- 117-3, Hoegi-ro, Dongdaemun
- Seoul, 02455
- South Korea
Corporate Office
- Room 501, Seoul Biohub Global Center
- 117-3, Hoegi-ro, Dongdaemun
- Seoul, 02455
- South Korea
TwinPig BioLab Timeline
TwinPig BioLab Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 20-Nov-2025 | Completed | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC (Series B) | 20-Nov-2025 | Completed | Clinical Trials - Phase 2 | |||
| 5. Early Stage VC (Series A) | 01-Jan-2023 | Completed | Clinical Trials - Phase 2 | |||
| 4. Accelerator/Incubator | 26-Oct-2022 | Completed | Clinical Trials - Phase 2 | |||
| 3. Accelerator/Incubator | 29-Sep-2022 | Completed | Clinical Trials - Phase 2 | |||
| 2. Accelerator/Incubator | 01-Oct-2020 | Completed | Startup | |||
| 1. Seed Round | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
TwinPig BioLab Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
TwinPig BioLab Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
TwinPig BioLab Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| LS Securities | Investment Bank | Minority | ||
| Pathfinder H | Venture Capital | Minority | ||
| Scale Up Partners | Accelerator/Incubator | Minority | ||
| Wooshin Venture Investment | Venture Capital | Minority | ||
| Genaxis (Korea) | Venture Capital | Minority |
TwinPig BioLab FAQs
-
When was TwinPig BioLab founded?
TwinPig BioLab was founded in 2019.
-
Where is TwinPig BioLab headquartered?
TwinPig BioLab is headquartered in Seoul, South Korea.
-
What is the size of TwinPig BioLab?
TwinPig BioLab has 12 total employees.
-
What industry is TwinPig BioLab in?
TwinPig BioLab’s primary industry is Drug Discovery.
-
Is TwinPig BioLab a private or public company?
TwinPig BioLab is a Private company.
-
What is TwinPig BioLab’s current revenue?
The current revenue for TwinPig BioLab is .
-
How much funding has TwinPig BioLab raised over time?
TwinPig BioLab has raised $1.74M.
-
Who are TwinPig BioLab’s investors?
LS Securities, Pathfinder H, Scale Up Partners, Wooshin Venture Investment, and Genaxis (Korea) are 5 of 8 investors who have invested in TwinPig BioLab.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
